As evidence accrues, we, and others, will monitor what it means for the impact of GLP-1 medications on SMM, but so far we have not seen any compelling clinical data (although new systematic reviews and meta analyses have been proposed ) that GLP-1 medications lead to pathological skeletal muscle mass loss relative to what has been demonstrated and observed in other weight loss interventions
The four subcutaneous areas that work best are the lower abdomen (away from the navel), the outer thigh, the back of the upper arm, and the flank or love-handle area
For recovery-focused patients, our Wolverine protocol (BPC-157 + TB-500) addresses tissue repair through complementary mechanisms
Vitamin D Supplements vs
Chiappini S, Vickers-Smith R, Harris D, Papanti Pelletier GD, Corkery JM, Guirguis A, et al